FDA's ad en­forcer cri­tiques Brit­tany Ma­home­s' paid In­sta­gram post for Kaléo

Brit­tany Ma­homes’ In­sta­gram is the sub­ject of a re­cent let­ter the FDA sent to Kaléo re­gard­ing a mis­lead­ing di­rect-to-con­sumer ad for its ep­i­neph­rine in­jec­tion. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER